Literature DB >> 23455877

Improvements in outcomes in methadone patients on probation/parole regardless of counseling early in treatment.

Sharon M Kelly1, Kevin E Oʼgrady, Jerome H Jaffe, Devang Gandhi, Robert P Schwartz.   

Abstract

OBJECTIVE: This secondary data analysis examined the association between criminal justice (CJ) status and outcomes over 12 months of methadone maintenance treatment.
METHODS: In the parent study, 230 newly admitted patients were randomly assigned to methadone either with or without counseling for 4 months followed by standard methadone with counseling. Participants completed the ASI and urine drug testing at baseline and 4- and 12-month follow-up and the Treatment Readiness (TR) scale at baseline. The relationship between baseline CJ status (whether participants were on probation or parole), CJ status by study counseling condition, and CJ status by TR with heroin and cocaine use, illegal activity, days in treatment and treatment retention, arrests, and the number of days incarcerated or hospitalized during follow-up was examined.
RESULTS: Compared with participants not on probation/parole, probationers/parolees showed significant reductions in cocaine-positive tests from baseline to 12 months (P < 0.001). Probationers/parolees additionally reported significantly fewer days of illegal activity than nonprobationers/parolees at 12 months (P = 0.02). There was no relationship between CJ status and counseling condition for any outcomes. The relationship between CJ status and TR was significant only for cocaine-positive tests assessed over time (P = 0.017).
CONCLUSIONS: Findings suggest that methadone participants on probation/parole showed improvements in outcomes in comparison with participants not on probation/parole, regardless of whether they received counseling during the first 4 months of treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23455877      PMCID: PMC3618548          DOI: 10.1097/ADM.0b013e318284a0c1

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  24 in total

1.  Characteristics of criminal justice and noncriminal justice clients receiving treatment for substance abuse.

Authors:  Grant N Marshall; Yih-Ing Hser
Journal:  Addict Behav       Date:  2002 Mar-Apr       Impact factor: 3.913

2.  Factors associated with methadone maintenance treatment retention among street-recruited injection drug users.

Authors:  Robert E Booth; Karen F Corsi; Susan K Mikulich-Gilbertson
Journal:  Drug Alcohol Depend       Date:  2004-05-10       Impact factor: 4.492

3.  Compulsory supervision and methadone maintenance.

Authors:  D P Desmond; J F Maddux
Journal:  J Subst Abuse Treat       Date:  1996 Jan-Feb

4.  Treatment effectiveness for legally coerced versus voluntary methadone maintenance clients.

Authors:  M L Brecht; M D Anglin; J C Wang
Journal:  Am J Drug Alcohol Abuse       Date:  1993       Impact factor: 3.829

5.  Reasons for discharge from methadone maintenance for addicts at high risk of HIV infection or transmission.

Authors:  C E Grella; M D Anglin; S E Wugalter; R Rawson; A Hasson
Journal:  J Psychoactive Drugs       Date:  1994 Apr-Jun

6.  Legal coercion and retention in drug abuse treatment.

Authors:  J J Collins; M Allison
Journal:  Hosp Community Psychiatry       Date:  1983-12

7.  Impact of methadone with versus without drug abuse counseling on HIV risk: 4- and 12-month findings from a clinical trial.

Authors:  Sharon M Kelly; Robert P Schwartz; Kevin E Oʼgrady; Devang Gandhi; Jerome H Jaffe
Journal:  J Addict Med       Date:  2012-06       Impact factor: 3.702

8.  Pre- and in-treatment predictors of retention in methadone treatment using survival analysis.

Authors:  S Magura; P C Nwakeze; S Y Demsky
Journal:  Addiction       Date:  1998-01       Impact factor: 6.526

9.  The Fifth Edition of the Addiction Severity Index.

Authors:  A T McLellan; H Kushner; D Metzger; R Peters; I Smith; G Grissom; H Pettinati; M Argeriou
Journal:  J Subst Abuse Treat       Date:  1992

10.  The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis.

Authors:  L A Marsch
Journal:  Addiction       Date:  1998-04       Impact factor: 6.526

View more
  9 in total

1.  Treatment Outcomes of African American Buprenorphine Patients by Parole and Probation Status.

Authors:  Shannon Gwin Mitchell; Jan Gryczynski; Sharon M Kelly; Kevin E O'Grady; Jerome H Jaffe; Yngvild K Olsen; Robert P Schwartz
Journal:  J Drug Issues       Date:  2014-01

2.  Community correctional agents' views of medication-assisted treatment: Examining their influence on treatment referrals and community supervision practices.

Authors:  Shannon Gwin Mitchell; Jennifer Willet; Laura B Monico; Amy James; Danielle S Rudes; Jill Viglione; Robert P Schwartz; Michael S Gordon; Peter D Friedmann
Journal:  Subst Abus       Date:  2016       Impact factor: 3.716

3.  Pharmacotherapy for opioid addiction in community corrections.

Authors:  Robert P Schwartz; Mary M Mitchell; Kevin E O'Grady; Sharon M Kelly; Jan Gryczynski; Shannon Gwin Mitchell; Michael S Gordon; Jerome H Jaffe
Journal:  Int Rev Psychiatry       Date:  2018-12-06

4.  Barriers to Medications for Opioid Use Disorder Among Veterans Involved in the Legal System: a Qualitative Study.

Authors:  Andrea K Finlay; Erica Morse; Matthew Stimmel; Emmeline Taylor; Christine Timko; Alex H S Harris; David Smelson; Mengfei Yu; Jessica Blue-Howells; Ingrid A Binswanger
Journal:  J Gen Intern Med       Date:  2020-06-24       Impact factor: 5.128

5.  Buprenorphine Treatment for Probationers and Parolees.

Authors:  Michael S Gordon; Timothy W Kinlock; Robert P Schwartz; Kathryn A Couvillion; Laura J Sudec; Kevin E O'Grady; Frank J Vocci; Hamin Shabazz
Journal:  Subst Abus       Date:  2014-04-04       Impact factor: 3.716

6.  Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients.

Authors:  Andrea K Finlay; Alex H S Harris; Joel Rosenthal; Jessica Blue-Howells; Sean Clark; Jim McGuire; Christine Timko; Susan M Frayne; David Smelson; Elizabeth Oliva; Ingrid Binswanger
Journal:  Drug Alcohol Depend       Date:  2016-01-24       Impact factor: 4.492

7.  Clinical validation of reduction in cocaine frequency level as an endpoint in clinical trials for cocaine use disorder.

Authors:  Corey R Roos; Charla Nich; Chung Jung Mun; Theresa A Babuscio; Justin Mendonca; André Q C Miguel; Elise E DeVito; Sarah W Yip; Katie Witkiewitz; Kathleen M Carroll; Brian D Kiluk
Journal:  Drug Alcohol Depend       Date:  2019-10-21       Impact factor: 4.492

Review 8.  Substance misuse and community supervision: A systematic review of the literature.

Authors:  Coral Sirdifield; Charlie Brooker; Rebecca Marples
Journal:  Forensic Sci Int Mind Law       Date:  2020-11

9.  HIV-Risk Behavior Among Adults with Opioid Use Disorder During 12 Months Following Pre-trial Detention: Results from a Randomized Trial of Methadone Treatment.

Authors:  M M Mitchell; S M Kelly; K E O'Grady; J H Jaffe; S G Mitchell; R P Schwartz
Journal:  AIDS Behav       Date:  2020-11-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.